H2AX is required for cell cycle arrest via the p53/p21 pathway.

Michalis Fragkos, Jaana Jurvansuu, Peter Beard
Author Information
  1. Michalis Fragkos: Ecole Polytechnique Federale de Lausanne, Faculty of Life Sciences, Swiss Institute for Experimental Cancer Research, 1015 Lausanne, Switzerland.

Abstract

Phosphorylation of H2AX (gammaH2AX) is an early sign of DNA damage induced by replication stalling. However, the role of H2AX in the repair of this type of DNA damage is still unclear. In this study, we used an inactivated adeno-associated virus (AAV) to induce a stalled replication fork signal and investigate the function of gammaH2AX. The cellular response to AAV provides a unique model to study gammaH2AX function, because the infection causes pannuclear H2AX phosphorylation without any signs of damage to the host genome. We found that pannuclear gammaH2AX formation is a result of ATR overactivation and diffusion but is independent of ATM. The inhibition of H2AX with RNA interference or the use of H2AX-deficient cells showed that gammaH2AX is dispensable for the formation and maintenance of DNA repair foci induced by stalled replication. However, in the absence of H2AX, the AAV-containing cells showed proteosome-dependent degradation of p21, followed by caspase-dependent mitotic catastrophe. In contrast, H2AX-proficient cells as well as H2AX-complemented H2AX(-/-) cells reacted by increasing p21 levels and arresting the cell cycle. The results establish a new role for H2AX in the p53/p21 pathway and indicate that H2AX is required for p21-induced cell cycle arrest after replication stalling.

References

  1. Cell. 2003 Aug 8;114(3):371-383 [PMID: 12914701]
  2. Curr Biol. 2000 Jul 27-Aug 10;10(15):886-95 [PMID: 10959836]
  3. Oncogene. 1997 Jul 10;15(2):159-67 [PMID: 9244351]
  4. Curr Opin Genet Dev. 2002 Apr;12(2):162-9 [PMID: 11893489]
  5. Mol Cell. 2005 Jun 10;18(6):617-22 [PMID: 15949437]
  6. Oncogene. 2001 Apr 5;20(15):1803-15 [PMID: 11313928]
  7. Oncogene. 1999 Sep 23;18(39):5403-12 [PMID: 10498894]
  8. Mol Cell Biol. 2005 May;25(9):3553-62 [PMID: 15831461]
  9. Cancer Res. 2005 May 15;65(10):3980-5 [PMID: 15899785]
  10. Nat Cell Biol. 2002 Dec;4(12):993-7 [PMID: 12447390]
  11. Mol Cell Biol. 2005 Oct;25(20):8925-37 [PMID: 16199871]
  12. Nature. 2000 Dec 21-28;408(6815):1001-4 [PMID: 11140636]
  13. Nature. 1996 Jun 20;381(6584):713-6 [PMID: 8649519]
  14. Curr Opin Cell Biol. 2001 Dec;13(6):738-47 [PMID: 11698191]
  15. J Virol Methods. 2004 Dec 1;122(1):17-27 [PMID: 15488616]
  16. Nature. 2001 Aug 30;412(6850):914-7 [PMID: 11528480]
  17. Mol Cell. 2000 Feb;5(2):403-10 [PMID: 10882081]
  18. Virology. 1988 Dec;167(2):393-9 [PMID: 2849233]
  19. Genes Dev. 2008 Feb 1;22(3):297-302 [PMID: 18245444]
  20. J Cell Biochem. 2006 Dec 1;99(5):1452-62 [PMID: 16927366]
  21. Cell Cycle. 2003 Sep-Oct;2(5):426-7 [PMID: 12963833]
  22. Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13634-9 [PMID: 16157891]
  23. Cancer Cell. 2005 Feb;7(2):113-4 [PMID: 15710322]
  24. J Virol. 2005 Jan;79(1):569-80 [PMID: 15596849]
  25. Nat Cell Biol. 2003 Jul;5(7):675-9 [PMID: 12792649]
  26. Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8173-8 [PMID: 12034884]
  27. J Biol Chem. 2003 May 30;278(22):20303-12 [PMID: 12660252]
  28. Cell. 2003 Oct 3;115(1):71-82 [PMID: 14532004]
  29. Cell. 2003 Sep 5;114(5):599-610 [PMID: 13678583]
  30. Science. 1998 Nov 20;282(5393):1497-501 [PMID: 9822382]
  31. J Biol Chem. 2004 Feb 13;279(7):5802-10 [PMID: 14597617]
  32. Science. 2002 May 3;296(5569):922-7 [PMID: 11934988]
  33. Cell Cycle. 2004 Feb;3(2):149-53 [PMID: 14712078]
  34. J Biol Chem. 2001 Dec 21;276(51):47759-62 [PMID: 11673449]
  35. Biochem Biophys Res Commun. 2002 Oct 11;297(5):1318-23 [PMID: 12372432]
  36. J Virol. 2008 Aug;82(15):7379-87 [PMID: 18463154]
  37. Cancer Res. 2007 Aug 15;67(16):7631-7 [PMID: 17699767]
  38. Oncogene. 1999 Feb 4;18(5):1239-44 [PMID: 10022130]
  39. Oncogene. 2005 Apr 18;24(17):2899-908 [PMID: 15838523]
  40. Oncogene. 2007 Feb 15;26(7):993-1002 [PMID: 16909103]
  41. Mol Cell. 2006 Jan 20;21(2):201-14 [PMID: 16427010]
  42. FEBS Lett. 2006 Nov 13;580(26):6100-4 [PMID: 17054950]
  43. Oncogene. 2007 Jul 19;26(33):4806-16 [PMID: 17297446]
  44. Oncogene. 2008 Jan 31;27(6):732-40 [PMID: 17653085]
  45. Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9092-7 [PMID: 11481475]
  46. J Cell Biol. 2006 Apr 24;173(2):195-206 [PMID: 16618811]
  47. Cancer Res. 1999 Sep 1;59(17):4375-82 [PMID: 10485486]
  48. DNA Repair (Amst). 2004 Aug-Sep;3(8-9):959-67 [PMID: 15279782]
  49. Mol Cell. 2007 Aug 3;27(3):462-73 [PMID: 17679094]
  50. Cancer Res. 2000 Feb 1;60(3):679-84 [PMID: 10676653]
  51. Science. 2008 Jun 13;320(5882):1507-10 [PMID: 18483401]
  52. J Cell Biol. 1999 Sep 6;146(5):905-16 [PMID: 10477747]
  53. Cell. 2007 May 18;129(4):665-79 [PMID: 17512402]
  54. J Biol Chem. 1998 Mar 6;273(10):5858-68 [PMID: 9488723]
  55. Cell Cycle. 2006 Dec;5(24):2899-902 [PMID: 17172866]
  56. J Biol Chem. 2004 Oct 29;279(44):45810-4 [PMID: 15308627]
  57. J Mol Biol. 2007 Sep 14;372(2):397-406 [PMID: 17663993]

MeSH Term

Ataxia Telangiectasia Mutated Proteins
Cell Cycle
Cell Cycle Proteins
Cell Line
Cell Nucleus
Cyclin-Dependent Kinase Inhibitor p21
DNA Damage
DNA Repair
DNA-Binding Proteins
Dependovirus
Histones
Humans
Protein Serine-Threonine Kinases
RNA Interference
Tumor Suppressor Protein p53
Tumor Suppressor Proteins

Chemicals

Cell Cycle Proteins
Cyclin-Dependent Kinase Inhibitor p21
DNA-Binding Proteins
H2AX protein, human
Histones
Tumor Suppressor Protein p53
Tumor Suppressor Proteins
ATM protein, human
ATR protein, human
Ataxia Telangiectasia Mutated Proteins
Protein Serine-Threonine Kinases

Word Cloud

Created with Highcharts 10.0.0H2AXgammaH2AXreplicationcellsDNAdamagecellcycleinducedstallingHoweverrolerepairstudyAAVstalledfunctionpannuclearformationshowedp21p53/p21pathwayrequiredarrestPhosphorylationearlysigntypestillunclearusedinactivatedadeno-associatedvirusinduceforksignalinvestigatecellularresponseprovidesuniquemodelinfectioncausesphosphorylationwithoutsignshostgenomefoundresultATRoveractivationdiffusionindependentATMinhibitionRNAinterferenceuseH2AX-deficientdispensablemaintenancefociabsenceAAV-containingproteosome-dependentdegradationfollowedcaspase-dependentmitoticcatastrophecontrastH2AX-proficientwellH2AX-complemented-/-reactedincreasinglevelsarrestingresultsestablishnewindicatep21-inducedvia

Similar Articles

Cited By (93)